1)National Institute for Health and Clinical Excellence(NICE):Borderline personality disorder:treatment and management:NICE clinical guideline 78. 2009 https://nice.org.uk/guidance/cg78(2020年2月20日閲覧)
2)National Institute for Health and Clinical Excellence(NICE):NICE Pathways Borderline personality disorder. https://pathways.nice.org.uk/pathways/personality-disorders#path=view%3A/pathways/personality-disorders/borderline-personality-disorder.xml&content=view-index.(2020年2月20日閲覧)
3)American Psychiatric Association:Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 158(Suppl 10):1-52, 2001
4)National Health and Medical Research Council:Clinical practice guideline for the management of borderline personality disorder. National Health and Medical Research Council, Melbourne, 2012
5)Stoffers JM, Vollm BA, Rucker G, et al:Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 8:Cd005652, 2012
6)Linehan MM:Cognitive-behavioral Treatment of Borderline Personalit6y Disorder. Guilford Press, New York, 1993
7)Bateman A, Fonagy P:Psychotherapy for borderline personality disorder:mentalization-based treatment. Oxford University Press, New York, 2004
8)Brettschneider C, Riedel-Heller S, Konig HH:A systematic review of economic evaluations of treatments for borderline personality disorder. PLoS One 9:e107748, 2014
9)National Institute for Health and Clinical Excellence(NICE):2018 surveillance of personality disorders(NICE guidelines CG77 and CG78). https://www.nice.org.uk/guidance/cg78/resources/2018-surveillance-of-personality-disorders-nice-guidelines-cg77-and-cg78-4906490080/chapter/Surveillance-decision?tab=evidence.(2020年2月20日閲覧)
10)Herpertz SC, Zanarini M, Schulz CS, et al:World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for biological treatment of personality disorders. World J Biol Psychiatry 8:212-244, 2007
11)Lieb K, Vollm B, Rucker G, et al:Pharmacotherapy for borderline personality disorder:Cochrane Syst Rev randomised trials. Br J Psychiatry 196:4-12, 2010
12)Kendall T, Burbeck R, Bateman A:Pharmacotherapy for borderline personality disorder:NICE guideline. Br J Psychiatry 196:158-159, 2010
13)Haw C, Stubbs J:Medication for borderline personality disorder:a survey at a secure hospital. Int J Psychiatry Clin Pract 15:280-285, 2011